This text is a result of machine translation.
The first eight carbon neutral ETFs were approved today
Many banks have issued documents to stop the intelligent investment advisory business. Insiders: it may be restarted after the regulatory rules are released
Xiaopeng automobile was reduced by JPMorgan Chase by HK $365million
Mihayou v. Minmetals trust case will hold a court session, and it is difficult to recover the funds involved in the thunderstorm products
Financing and Investment Activities in China's Mobility Industry From 2012 to 2022
Mihayou sued Minmetals trust
The southbound capital flowed in sharply today. So far, the net inflow has reached 5billion yuan.
RMB 12.1 billion was collected, and the second batch of 8 plots of centralized land supply in Dongguan were all sold
Xiangjiang Holdings: it plans to terminate some projects invested with raised funds and permanently supplement the remaining raised funds with working capital
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Russian finance minister says West creates artificial obstacles for Russia to repay public debt
The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan
IGC raised its global soybean production forecast for 2022/23 to 390million tons
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Mar 31, 2021 11:38 AM
"Wuyang bond" has paid more than 500 million yuan to deppon securities to recover 315 million yuan from other three parties
Changes in the aquaculture sector pulled Fucheng shares up by the daily limit
The private placement market is full of chaos, and the regulators' sword is intended to support the good and limit the bad
Stocks in the breeding industry rose in early trading
Interview With TI5 ROBOT: The Rise of the Robot Industry
May 18, 2023 10:38 AM
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
May 12, 2023 01:33 PM